Surgical Science Sweden AB (OSTO:SUS) Cyclically Adjusted Revenue per Share: kr10.39 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:SUS Surgical Science Sweden AB OSTO:SUS
85 GF Score
Price kr30.84
GF Value kr153.39
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Surgical Science Sweden AB Cyclically Adjusted Revenue per Share?

Surgical Science Sweden AB OSTO:SUS +2.12% 85 Cyclically Adjusted Revenue per Share is kr10.39 as of Mar. 2026. GuruFocus rates OSTO:SUS with a GF Score™ of 85/100 and a GF Value™ of kr153.39 (Significantly Undervalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Surgical Science Sweden AB's adjusted revenue per share for the three months ended in Mar. 2026 was kr4.615. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is kr10.39 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-07-26), Surgical Science Sweden AB's current stock price is kr30.84. Surgical Science Sweden AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was kr10.39. Surgical Science Sweden AB's Cyclically Adjusted PS Ratio of today is 2.97.

During the past 11 years, the highest Cyclically Adjusted PS Ratio of Surgical Science Sweden AB was 9.34. The lowest was 2.47. And the median was 3.19.


Surgical Science Sweden AB  (OSTO:SUS) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Surgical Science Sweden AB's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=30.84/10.39
=2.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 11 years, the highest Cyclically Adjusted PS Ratio of Surgical Science Sweden AB was 9.34. The lowest was 2.47. And the median was 3.19.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Surgical Science Sweden AB Cyclically Adjusted Revenue per Share Related Terms


Surgical Science Sweden AB Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Surgical Science Sweden AB's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Surgical Science Sweden AB Cyclically Adjusted Revenue per Share Chart

Surgical Science Sweden AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 9.97

Surgical Science Sweden AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 9.69 9.97 10.39

OSTO:SUS vs VEEV, BTSG, TEM: Cyclically Adjusted Revenue per Share Comparison

For the Health Information Services subindustry, Surgical Science Sweden AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Surgical Science Sweden AB Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Surgical Science Sweden AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Surgical Science Sweden AB's Cyclically Adjusted PS Ratio falls into.


OSTO:SUS
85GF Score
Surgical Science Sweden AB OSTO:SUS
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Surgical Science Sweden AB Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Surgical Science Sweden AB's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=4.615/133.5600*133.5600
=4.615

Current CPI (Mar. 2026) = 133.5600.

Surgical Science Sweden AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.712 101.019 0.941
201609 0.206 101.138 0.272
201612 1.079 102.022 1.413
201703 0.456 102.022 0.597
201706 0.838 102.752 1.089
201709 0.403 103.279 0.521
201712 0.983 103.793 1.265
201803 0.457 103.962 0.587
201806 0.606 104.875 0.772
201809 0.554 105.679 0.700
201812 1.062 105.912 1.339
201903 0.554 105.886 0.699
201906 0.645 106.742 0.807
201909 1.030 107.214 1.283
201912 1.122 107.766 1.391
202003 0.578 106.563 0.724
202006 0.598 107.498 0.743
202009 0.723 107.635 0.897
202012 1.139 108.296 1.405
202103 1.000 108.360 1.233
202106 0.961 108.928 1.178
202109 2.152 110.338 2.605
202112 3.867 112.486 4.591
202203 3.122 114.825 3.631
202206 3.697 118.384 4.171
202209 4.029 122.296 4.400
202212 4.918 126.365 5.198
202303 4.500 127.042 4.731
202306 4.247 129.407 4.383
202309 4.120 130.224 4.226
202312 4.454 131.912 4.510
202403 3.689 132.205 3.727
202406 4.164 132.716 4.190
202409 4.543 132.304 4.586
202412 4.930 132.987 4.951
202503 4.913 132.825 4.940
202506 4.099 133.699 4.095
202509 5.167 133.480 5.170
202512 5.269 133.390 5.276
202603 4.615 133.560 4.615

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of kr10.39 mean?
Surgical Science Sweden AB (OSTO:SUS) has a Cyclically Adjusted Revenue per Share of kr10.39 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Surgical Science Sweden AB and its competitors.
Is Surgical Science Sweden AB's Cyclically Adjusted Revenue per Share too high?
Surgical Science Sweden AB's current Cyclically Adjusted Revenue per Share is kr10.39. Overall, Surgical Science Sweden AB has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Surgical Science Sweden AB's Cyclically Adjusted Revenue per Share compare to VEEV and BTSG?
Surgical Science Sweden AB's Cyclically Adjusted Revenue per Share of kr10.39 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Surgical Science Sweden AB and its competitors. Surgical Science Sweden AB's current Cyclically Adjusted Revenue per Share is kr10.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgical Science Sweden AB stock overvalued right now?
Based on GuruFocus' analysis, Surgical Science Sweden AB (OSTO:SUS) is currently considered Significantly Undervalued. The stock's GF Value™ is kr153.39, compared to a current price of kr30.84 — trading 79.9% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is kr10.39. Surgical Science Sweden AB's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Surgical Science Sweden AB (OSTO:SUS), the current Cyclically Adjusted Revenue per Share is kr10.39 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Surgical Science Sweden AB (OSTO:SUS) Overvalued in 2026?

Based on GuruFocus' analysis, Surgical Science Sweden AB stock appears to be undervalued. The current stock price of kr30.84 is trading 79.9% below its estimated GF Value™ of kr153.39. GuruFocus considers Surgical Science Sweden AB to be Significantly Undervalued.

Key valuation signals for OSTO:SUS:

  • Cyclically Adjusted Revenue per Share: kr10.39
  • GF Value™: kr153.39 vs. price of kr30.84 (79.9% below fair value)
  • GF Score™: 85/100 with 4 warning signs

No single metric tells the full story. See the OSTO:SUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Surgical Science Sweden AB Business Description

Other Exchanges SUSRF:USA4P41:Germany
Address Drakegatan 7A, Gothenburg, SWE, SE-412 50
Surgical Science Sweden AB is a supplier of virtual reality simulators for medical training. The company's core is its proprietary software and hardware for simulating interactions between instruments and anatomy. It has two operating segments: Educational products include Proprietary brand medical simulator hardware and software for generic training of psycho-motor skills, instrument handling, and training for a large number of procedures and examinations prior to entering the clinical environment, as well as support and services. Industry/OEM includes simulation software for product-specific training of surgeons in robot-assisted surgery and other digitalized medical instruments, and also simulators for medical device companies.
85GF Score

Get the complete analysis for OSTO:SUS

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr30.84
Price
kr153.39
GF Value